[O-10] Clinical trial

[O-10-4] Treatment of human cells derived from MERRF disease by peptide-mediated mitochondrial delivery

^○Chin-san Liu^1,2,5, Jui-Chih Chang², Ko-Hung Liu², Yau-Huei Wei³, Shou-Jen Kuo⁴ (1.Department of Neurology, Changhua Christian Hospital, Taiwan, 2.Vascular and Genomic Center, Changhua Christian Hospital,Changhua, Taiwan, 3.Center for Mitochondrial Medicine and Free Radical Research, Changhua Christian Hospital,Changhua, Taiwan, 4.Department of Surgery, Changhua Christian Hospital,Changhua, Taiwan, 5.Graduate Institute of Integrated Medicine,College of Chinese Medicine, China Medical University, Taichung, Taiwan)